Dog, intravenous LDLo: Cancer Chemotherapy Reports, 50(255), 1966; via PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/61475#section=Acute-Effects
Rat, intravenous LD50: Yakkyoku. Pharmacy, 31(959), 1980; via PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/61475#section=Acute-Effects
Human male, oral TDLo: Tohoku Journal of Experimental Medicine, 63(383), 1956 [PMID:13371588]; via PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/61475#section=Acute-Effects
This value was estimated from compound adjustment factor (CAF) using sodium thiosulfate as a basis. The sodium thiosulfate TEEL values were estimated using the methods: TEEL-2/11, TEEL-3/6, Dog intravenous, LD50. This resulted in TEEL values approximate 20% greater than the selected method for the chemical of interest. (Nutritional and Gross Metabolic; via PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/24477#section=NIOSH-Toxicity-Data)